Newborn Screening
The Delaware Public Health Laboratory Newborn Screening section tests for 37 genetic and metabolic diseases. Dried blood spot samples obtained from Delaware newborns are analyzed for the following: congenital hypothyroidism, congenital adrenal hyperplasia, galactosemia, sickle cell disease and other major hemoglobinopathies, amino acid disorders (e.g. phenylketonuria [PKU], maple syrup urine disease), organic acid disorders and fatty acid oxidation disorders (e.g. Medium Chain Acyl-CoA Dehydrogenase Deficiency [MCAD]). Early detection and management of these disorders prevents mental retardation and other catastrophic health problems in affected children.
Check here to visit the Newborn Screening Program page for more information.
Return to the Delaware Public Health Laboratory home page.
